Oncolytics Meets Primary Endpoint in U.S. Phase 2 Study of REOLYSIN®

News   May 28, 2013

 
Oncolytics Meets Primary Endpoint in U.S. Phase 2 Study of REOLYSIN®
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE